Leuthold Group LLC Sells 1,128 Shares of Tenet Healthcare Co. (NYSE:THC)

Leuthold Group LLC reduced its stake in shares of Tenet Healthcare Co. (NYSE:THC) by 3.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,959 shares of the company’s stock after selling 1,128 shares during the quarter. Leuthold Group LLC’s holdings in Tenet Healthcare were worth $4,413,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. New Wave Wealth Advisors LLC acquired a new stake in shares of Tenet Healthcare in the 4th quarter worth $343,000. Swedbank AB boosted its holdings in Tenet Healthcare by 100.0% in the fourth quarter. Swedbank AB now owns 40,000 shares of the company’s stock worth $5,049,000 after acquiring an additional 20,000 shares in the last quarter. Legacy Capital Group California Inc. acquired a new position in shares of Tenet Healthcare during the third quarter valued at about $1,055,000. Signet Financial Management LLC acquired a new stake in Tenet Healthcare in the 4th quarter worth approximately $1,526,000. Finally, China Universal Asset Management Co. Ltd. acquired a new position in Tenet Healthcare during the 4th quarter valued at approximately $410,000. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Stock Performance

Shares of THC stock opened at $129.57 on Friday. The company has a market capitalization of $12.32 billion, a P/E ratio of 4.02, a P/E/G ratio of 1.01 and a beta of 2.05. Tenet Healthcare Co. has a 12-month low of $88.98 and a 12-month high of $171.20. The business’s 50 day moving average is $132.90 and its two-hundred day moving average is $147.69. The company has a current ratio of 1.78, a quick ratio of 1.70 and a debt-to-equity ratio of 2.25.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. Analysts expect that Tenet Healthcare Co. will post 12.24 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on THC shares. Truist Financial dropped their price objective on shares of Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating on the stock in a report on Monday, January 6th. JPMorgan Chase & Co. reiterated an “overweight” rating and set a $175.00 price target on shares of Tenet Healthcare in a research note on Tuesday, December 17th. Barclays reduced their price objective on Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating for the company in a research note on Thursday, February 13th. KeyCorp cut their price target on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Finally, Raymond James cut shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price objective for the company. in a research note on Friday, November 22nd. Four research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $163.19.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.